AbbVie (ABBV) Operating Expenses (2016 - 2025)
Historic Operating Expenses for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $13.9 billion.
- AbbVie's Operating Expenses rose 3051.09% to $13.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $50.6 billion, marking a year-over-year increase of 2131.81%. This contributed to the annual value of $47.2 billion for FY2024, which is 1356.08% up from last year.
- As of Q3 2025, AbbVie's Operating Expenses stood at $13.9 billion, which was up 3051.09% from $10.5 billion recorded in Q2 2025.
- In the past 5 years, AbbVie's Operating Expenses ranged from a high of $16.6 billion in Q4 2024 and a low of $8.8 billion during Q1 2022
- Moreover, its 5-year median value for Operating Expenses was $10.0 billion (2021), whereas its average is $10.6 billion.
- Per our database at Business Quant, AbbVie's Operating Expenses skyrocketed by 7757.18% in 2021 and then plummeted by 1715.1% in 2023.
- AbbVie's Operating Expenses (Quarter) stood at $9.8 billion in 2021, then dropped by 1.97% to $9.6 billion in 2022, then increased by 15.46% to $11.1 billion in 2023, then skyrocketed by 49.4% to $16.6 billion in 2024, then decreased by 16.39% to $13.9 billion in 2025.
- Its Operating Expenses was $13.9 billion in Q3 2025, compared to $10.5 billion in Q2 2025 and $9.6 billion in Q1 2025.